Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lots of premature talk about loss of the MMP or PDS interest by TPL.

Sometime last year Moore mentioned that Leckrone attempted to sell TPL to no avail. I've never been able to rectify that in my mind. If there are so many parties interested in the portfolio, I wonder if the price was to steep or there just weren't any takers? Was Leckrone in trouble that early or did he see the value of the MMP finally coming to a head? There are to many questions at this juncture. Patriot has an obligation to address these issues. The Q just contained the minimum requirements of the SEC. If they really want to calm investors fears, PTSC should have released a letter addressing the situation.

Share
New Message
Please login to post a reply